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Murugesan Velayutham, PHD,* Orlando P. Simonetti, PHD,* Peter B. Baker, MD,†
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Jay L. Zweier, MD, FACC*
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O B J E C T I V E S We investigated the role of iron deposition in atherosclerotic plaque instability using
a novel approach of in vivo plaque characterization by a noninvasive, noncontrast magnetic resonance-
based T2* measurement. This approach was validated using ex vivo plaque analyses to establish that T2*
accurately reﬂects intraplaque iron composition.
B A C KG ROUND Iron catalyzes free radical production, a key step for lipid peroxidation and
atherosclerosis development. The parameter T2* measures tissue magnetic susceptibility, which
historically has been used to quantify hepatic and myocardial iron. The T2* measurement has not been
used for in vivo plaque characterization in patients with atherosclerosis.
METHOD S Thirty-nine patients referred for carotid endarterectomy were prospectively enrolled to
undergo preoperative carotid magnetic resonance imaging (MRI) and postoperative analysis of the
explanted plaque. Clinical history of any symptoms attributable to each carotid lesion was recorded. We
could not complete MRI in 4 subjects because of their claustrophobia, and 3 patients scanned before the
institution of a neck stabilizer had motion artifact, precluding quantiﬁcation.
R E S U L T S Symptomatic patients had signiﬁcantly lower plaque T2* values (20.0 1.8 ms) compared
with asymptomatic patients (34.4  2.7 ms, p  0.001). Analytical methods demonstrated similar total
iron (138.6  36.5 g/g vs. 165.8  48.3 g/g, p  NS) but less low molecular weight Fe(III) (7.3  3.8
g/g vs. 17.7  4.0 g/g, p  0.05) in the explanted plaques of symptomatic versus asymptomatic
patients, respectively, which is consistent with a shift in iron from Fe(III) to greater amounts of
T2*-shortening forms of iron. Mass spectroscopy also showed signiﬁcantly lower calcium (37.5  10.8
mg/g vs. 123.6  19.3 mg/g, p  0.01) and greater copper (3.2  0.5 g/g vs. 1.7  0.1 g/g, p  0.01)
in plaques from symptomatic patients.
CONC L U S I O N S In vivo measurement of intraplaque T2* using MRI is feasible and distinguishes
symptom-producing from non–symptom-producing plaques in patients with carotid artery atherosclerosis.
Symptom-producing plaques demonstrated characteristic changes in iron forms by ex vivo analysis,
supporting the dynamic presence of iron in the microenvironment of atherosclerotic plaque. (J Am Coll
Cardiol Img 2008;1:49–57) © 2008 by the American College of Cardiology Foundation
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50therosclerosis is a major cause of cardiovascular
disease, including acute coronary syndromes
and ischemic strokes. With increasing recog-
nition that the plaque microenvironment
etermines clinical sequelae rather than degree of
essel stenosis alone, better strategies to character-
ze plaque are needed to improve prevention and
treatment (1,2). Since Sullivan (3) first
proposed that relative iron depletion was
protective against cardiovascular disease,
the quest to demonstrate iron’s role in
atherosclerosis has focused on its ability to
catalyze the peroxidation of low-density
lipoprotein (LDL). Microhemorrhage into
atherosclerotic plaque with macrophage-
mediated phagocytosis and degradation of
aged red blood cells leads to accumulation of
redox-active iron (4,5). Via Fenton chemis-
try, iron catalyzes the generation of oxidized
LDL (Fig. 1) (6,7). Oxidized LDL, but not
native LDL, binds the macrophage
scavenger-receptor, leading to unregulated
uptake, foam cell formation, and accelerated
therogenesis (8–10).
See page 58
Despite these established pathophysiologic mecha-
isms, studies relating iron and atherosclerosis have
rovided conflicting results. Iron has consistently been
ound in greater concentrations in atherosclerotic
laque compared with normal arterial tissue (11,12).
Fenton chemistry
Fe3+ + O2
.
– Fe2+ + O2
Haber-Weiss reaction
O2
.
– + H2O2 O2 + OH
. 
+ OH–
LDL peroxidation
OH. + LDL H2O + LDL-ox
Fe2+ + H2O2 Fe3+ + OH
. 
+ OH–
Figure 1. LDL Peroxidation Catalyzed by Iron
The Haber-Weiss reaction and Fenton chemistry use iron in gen-
erating free radicals that oxidize low-density lipoprotein (LDL).
Microhemorrhage into atherosclerotic plaque with macrophage-
mediated phagocytosis and degradation of aged red blood cells
leads to accumulation of redox-active iron. Oxidized LDL binds
the macrophage scavenger-receptor, leading to unregulated
ic
d
in
htedw
uptake, foam cell formation, and accelerated atherogenesis.n animal models, iron overload accelerates athero-
enesis (13). Epidemiologic studies, however, have
ielded equivocal results when comparing serologic
arkers of total body iron stores with the incidence of
therosclerotic disease (14–17).
Notably, little work has involved direct in vivo
xamination of plaque iron, particularly with an ap-
reciation of the different species of iron in biologic
issues. Free or low molecular weight iron exists as
e(II) and Fe(III) cations. Iron may be incorporated
nto hemoglobin or bound to the storage proteins
erritin and hemosiderin, both of which cause mea-
urable changes in local magnetic field homogeneity.
his change can be appreciated qualitatively using
agnetic resonance T2*-weighted imaging (18) or
uantified using the relaxation parameter T2*. T2*
uantification allows for the accurate estimation of
issue iron content (19). Multiple in vivo and ex vivo
echniques exist to measure these various forms of iron
Table 1). Inductively coupled plasma mass spectros-
opy (ICP-MS) is used to measure total iron content.
lectron paramagnetic resonance (EPR) is sensitive to
everal forms of iron, iron storage, and iron transport
roteins; the g  4 peak is specific for Fe(III) with
hombic coordination symmetry. Electron paramag-
etic resonance does not detect the reduced state of
ron, Fe(II). T2*-weighted magnetic resonance imag-
ng (MRI) has been proven to be particularly sensitive
o iron clusters as occurs in ferritin- or hemosiderin-
ound iron (20) but, to date, a quantitative estimation
f T2* has not been used to understand iron’s role in
he microenvironment of human atherosclerotic
laque (19,21).
Recognizing that MRI is already established as a
eans for high-resolution in vivo imaging of carotid
rtery atherosclerotic plaque (22), we hypothesized
hat T2*-weighted MRI could uniquely evaluate the
elationship between atherosclerosis and iron. Specif-
cally, we sought in this work to: 1) validate the
easibility of in vivo T2*-based MRI carotid plaque
haracterization; and 2) to use both in vivo and ex vivo
nalyses to identify changes in iron content that
istinguish symptomatic from asymptomatic patients
Table 1. Iron Quantiﬁcation Techniques
Method Type of Iron Detected
Inductively-coupled plasma mass
spectroscopy
Total iron
Electron paramagnetic resonance Low molecular weight
Fe(III)
T2* magnetic resonance imaging Iron aggregatesB B R E V I A T I O N S
N D A C R O N YM S
PR electron paramagnet
esonance
CP-MS inductively couple
lasmamass spectroscopy
DL low-density lipoprote
RImagnetic resonance
maging
DW proton density-weig
E echo time
1W T1-weightedith carotid atherosclerosis.
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51E T H O D S
atient population. Thirty-nine patients referred for
arotid endarterectomy were prospectively enrolled.
atients with ferromagnetic metal, active implants
uch as pacemakers, aneurysm clips, known claustro-
hobia, and those who were unable to provide in-
ormed consent were excluded from enrollment. No
atients had hemochromatosis or significant transfu-
ion history. Patients gave written informed consent to
articipate in this Institutional Review Board–
pproved human subjects investigation. Clinical as-
essment at baseline using both patient interview and
hart review documented presence or absence of
ymptoms (symptomatic and asymptomatic patients,
espectively) attributable to the carotid artery disease,
uch as transient ischemic attack or cerebrovascular
ccident in the distribution of the diseased artery and
bsence of other source of embolism.
reoperative in vivo carotid magnetic resonance pro-
ocol. Carotid magnetic resonance examinations were
erformed using a 1.5-T scanner (Magnetom Avanto,
iemens Medical Solutions, Inc., Malvern, Pennsyl-
ania) and 4-channel surface radiofrequency coils
laced over the neck (Machnet BV, Eelde, the Neth-
rlands). After localization, single-shot axial steady-
tate free precession images were acquired using thin
verlapping sections. These sections were transferred
o a 3-dimensional viewer for localization of a plane
emonstrating maximum carotid plaque; this slice
ocation was then used for T2* measurement. T2*, a
elaxation parameter that has been shown to be
irectly related to iron content in other tissues (23),
as measured in the predetermined slice using an
lectrocardiography-triggered, segmented, multiple-
cho, gradient-echo acquisition with echo times (TEs)
f 2.7, 7.6, 12.5, 17.4, and 22.5 ms. Chemical shift
elective fat suppression and double inversion recovery
lood suppression were both used to improve delin-
ation of the vessel wall. Matrix size and field of view
rovided in-plane spatial resolution of 0.5  0.5 mm
nd slice thickness was 3 mm for these acquisitions.
sing the images from all 5 TEs, a region of interest
as drawn encompassing the plaque and a monoex-
onential decay curve was fit to compute T2*.
A subset of patients also underwent T1-weighted
T1W), T2-weighted (T2W), and proton density-
eighted (PDW) imaging at the same locations as
2* imaging. Typical scan parameters for these addi-
ional acquisitions were as follows. For T1W: TR 986
s, TE 9 ms; for T2W: TR 1,978 ms, TE 79 ms; and
or PDW: TR 2,030 ms, TE 9 ms. All were acquired
ith 3-mm slice thickness and 0.5 0.5 mm in-plane (esolution. As previously done, each of these images
as rated qualitatively as hypointense, isointense, or
yperintense based on signal intensity relative to
keletal muscle in the same image. T1W, T2W,
DW, and T2* image analysis were all performed
linded to patient history. Carotid T2* measurement
eproducibility was confirmed by having the same T2*
agnetic resonance images processed by 2 indepen-
ent observers and by having a subset of patients
ndergo repeated T2* MRI acquisitions at adjacent
lice locations.
x vivo plaque analysis. With explantation of the
laque at carotid endarterectomy, each patient’s ca-
otid plaque was divided into halves. One-half under-
ent fixation and sectioning for histopathology, in-
luding staining with hematoxylin and eosin and
russian blue. Slides were also stained for glycophorin
and factor VIII. Histopathology slides were in-
pected by a single cardiovascular pathologist (P. B.),
ho assigned plaque stage (I to VI), Prussian blue
core (0 to 4), glycophorin A score (0 to 4), and
actor VIII score (0 to 4) by aggregate review of all
lides for each patient blinded to symptom status (24).
he other one-half of the plaque was fresh-frozen for
ubsequent analysis with EPR to measure paramag-
etic iron species in the plaque followed by ICP-MS
o measure total iron content.
We recorded EPR spectra with a finger Dewar at
7 K with a Bruker ER 300 spectrometer (Bruker
ioSciences, Billerica, Massachusetts) operating at
-band with 100-KHz modulation frequency and a
M110 cavity as described previously (25). Tissue
amples (200 to 550 mg) were cut into small pieces
hat were loaded into the Dewar containing liquid
itrogen and placed within the EPR spectrometer
avity. The EPR instrument parameters used were as
ollows: gain 5  104, modulation amplitude 5 G,
ime constant 82 ms, scan time 131 s, microwave
ower 63 mW, and number of scans 10. A rhombic
ron signal was seen at g 4.3, which is characteristic
f low molecular weight iron complexes. Iron levels
ere quantified by comparing the amplitude of the
ignal with standard curves generated by using known
oncentrations of Fe(III)-desferrioxamine (1:1 com-
lex, generated from the addition of known concen-
rations of acidic FeCl3 standard to desferrioxamine
ollowed by titration to pH 6) under identical condi-
ions (26–28).
The total iron content of plaque in a portion of each
ample upon completion of EPR analysis was mea-
ured with ICP-MS. The samples were dried in an
ven at 100°C overnight. A portion of the sample
0.025 to 0.2 g) was placed inside a quartz vessel with
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52ml of high-purity (Fisher ACS Plus, Fisher Chem-
cal, Pittsburgh, Pennsylvania) nitric acid and 7 ml of
eionized water for digestion and then placed in a
losed trifluoromethoxyl vessel in an Ethos TC mi-
rowave digestion system (Milestone, Bergamo, Italy).
he temperature was increased from 0°C to 180°C in
he initial 10 min and then held at 180°C an addi-
ional 10 min before the vessels were cooled and
pened. Samples were diluted to 30 ml with deionized
ater and then placed into 30-ml low-density poly-
thylene plastic bottles. Samples were analyzed by
ither an Element 2 ICP-sector field-MS (Thermo
innigan, Bremen, Germany) used in medium reso-
ution (R  4,000) or a Sciex ELAN 6100DRCplus
PerkinElmer, Waltham, Massachusetts) with meth-
d Imaging and Intraplaque T2* Measurement
rk blood images at various echo times (A, echo time [TE] 2.7 ms;
5 ms; D, TE 17.4 ms) obtained at the location of maximum steno-
region of interest (D) on all the images encompassing the plaque
ean T2* within the plaque. See the text for T2* imaging scan
easured in a given plaque by ﬁtting the measured signal intensi-
xponential decay curve eTE/T2*. ECA  external carotid artery;
artery; J  internal jugular vein; VA  vertebral artery.ne as the reaction gas to minimize spectral overlaps so
hat iron could be measured at its major isotope.
alcium was measured at m/z 44 on the Element 2
nd m/z 40 on the ELAN DRCplus. Copper was
easured at m/z 63 and 65 on the Element 2 and m/z
5 on the ELAN DRCplus. Cobalt (100 ppb) was
dded to each sample and standard and used as an
nternal standard to correct for instrument drift and
hanges in sensitivity due to high, variable calcium
oncentrations. The samples were introduced into the
CP-MS by a PFA-ST concentric nebulizer (Ele-
ental Scientific, Omaha, Nebraska) and a PFA spray
hamber (Elemental Scientific). The sample was
umped at an uptake rate of 0.5 ml/min to the
ebulizer.
tatistical analysis. Continuous data are expressed as
ean  SE. The relationships between continuous
ariables were examined by nonparametric Spearman
orrelation. A nonparametric exact Wilcoxon rank
um test was used to compare symptomatic to asymp-
omatic patients with respect to each continuous
ariable. A value of p  0.05 was regarded as statis-
ically significant. Comparison of frequencies of pa-
ient characteristics was done using the Fisher exact
est.
E S U L T S
f the 39 study subjects, 19 were men (Table 2); all
omen in this study group were postmenopausal.
leven subjects had symptoms attributable to their
arotid artery disease: 6 strokes and 5 transient isch-
mic attacks occurred in the distribution of the carotid
esions. A total of 28 asymptomatic subjects had
igh-grade carotid artery stenosis identified by ultra-
onography that was prompted in most cases by
uscultatory findings on physical examination. Con-
rmation of stenosis severity to proceed with endar-
erectomy was provided in all subjects by either inva-
ive angiography (23 subjects) or contrast-enhanced
agnetic resonance angiography. Symptomatic and
symptomatic patient groups did not significantly
iffer in age (64.9  2.6 years vs. 66.5  1.2 years, p
Table 2. Patient Characteristics
Age, yrs 66.0  7.0
Male gender (%) 19 (49)
Diabetes, n (%) 16 (42)
Current or former smoker, n (%) 26 (72)
Symptomatic due to carotid lesion, n (%) 11 (28)
Serum hemoglobin, mg/dl 12.6  2.3Figure 2. T2*-Weighte
Serial T2*-weighted da
B, TE 7.6 ms; C, TE 12.
sis allow drawing of a
for measurement of m
parameters. (E) T2* is m
ties at each TE to an e0.70), frequency of diabetes (6 of 11 patients vs. 10
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53f 28 patients, p  0.47), or male gender (4 of 11
atients vs. 15 of 28 patients, p  0.48).
Four subjects, all asymptomatic, could not undergo
RI because of severe claustrophobia. Early in the
tudy, the MRI T2* acquisition in 3 subjects who had
ifficulty lying still, 1 symptomatic, resulted in severe
otion artifact and uninterpretable MRI data. Sub-
equent use of an inflatable neck cushion that fixed the
eck and coils in place during imaging eliminated
otion artifacts. Average time for carotid T2* data
cquisition was 1 min per slice. Sample magnetic
esonance acquisitions are shown in Figure 2. Plaque
2* measurements were significantly shorter, indicat-
ng greater levels of T2*-shortening iron, in plaques
rom symptomatic versus asymptomatic patients
mean 20.0 ms vs. 34.4 ms, respectively, p  0.001)
Fig. 3A). Repeated measurements showed good in-
erobserver agreement (r  0.88) of plaque T2*
uantification (Fig. 3B). T2* measurements compared
n 14 pairs of adjacent 3-mm image slices showed
ood reproducibility: the difference between T2* val-
es in adjacent slices averaged 6.5  4.4 ms. Addi-
ional T1W, T2W, and PDW imaging was per-
ormed in 11 subjects; their multispectral analyses are
ummarized in Table 3.
We found that EPR-detectable Fe(III) was present
n all but 4 patient plaques (3 symptomatic, 1 asymp-
omatic; p  NS) as a strong rhombic Fe(III) signal
ith a g value of 4.3, centered at 1,500 Gauss (Fig.
). This signal has been previously assigned to low
olecular weight Fe(III)-complexes (11). Quantita-
ive results from in vivo T2* measurements, EPR iron
ontent, and total iron, calcium, and copper content
y ICP-MS are summarized in Table 4. Both symp-
omatic patients and asymptomatic patients had
imilar levels of total iron by ICP-MS (mean 90.5 vs.
2.8 g/g, respectively). Whereas total iron content
Table 3. Multispectral Assessment and T2* Quantiﬁcation of Ca
Subject ID
Symptom
Status* MRI T1W† M
16 S 0
25 A 
32 A 0
33 A 
42 A 
43 A 0
46 A 0
48 A 0
50 A U
51 S 
*Symptom status (A  asymptomatic; S  symptomatic) determined by clinica
(U) for plaque signal intensity on T1-weighted (T1W), T2-weighted (T2W), and pro
by histopathology: Y  present; N  absent.p<0.001
T2
* (
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Figure 3. Intraplaque T2* by Symptom Status
(A) Plot of in vivo magnetic resonance-derived T2* values of carotid artery
plaque in asymptomatic versus symptomatic patients shows shorter T2*
times in symptomatic patients. Mean  SD is shown. (B) Bland-Altman anal-
ysis shows good agreement of carotid T2* measurement between indepen-rotid Plaque
RI T2W† MRI PDW†
MRI T2*,
ms
Intraplaque
Hemorrhage‡
0  14 Y
  35 Y
  27 N
  24 Y
  28 N
 0 25 N
 0 38 N
0  34 N
 U 32 N
  19 Y
l history and chart review. †Hypointense (), isointense (0), hyperintense (), or uninterpretable
ton density-weighted (PDW) magnetic resonance imaging (MRI). ‡Intraplaque hemorrhage deﬁned
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54y ICP-MS was similar, levels of paramagnetic
e(III) complexes by EPR were significantly lower in
laques from symptomatic versus asymptomatic pa-
ients (mean 7.3 vs. 17.7 g Fe(III)/g tissue wet
eight, p  0.025). There was significantly less
Figure 4. EPR Spectroscopy Detection of Iron in Carotid
Plaques
Electron paramagnetic resonance (EPR) is a powerful and mini-
mally invasive technique to identify and quantify the presence
of paramagnetic ferric iron [Fe(III)] within an explanted carotid
specimen. The EPR spectra were recorded on frozen tissue at 77
K. For further experimental details and spectrometer settings,
see the Methods section. Representative EPR spectra from con-
trol carotid artery (A), asymptomatic patient’s carotid plaque (B),
and symptomatic patient’s carotid plaque (C) are shown. Athero-
sclerotic plaque samples demonstrate the high-spin rhombic
iron species peak at a magnetic ﬁeld of 1,500 Gauss, corre-
sponding to a g value of 4.3. Although no rhombic iron signal
was observed in control carotid tissue, a prominent signal was
present in asymptomatic patients’ carotid plaques; however, in
symptomatic patients’ plaques, the level of this signal was sig-
niﬁcantly decreased.
Table 4. Results of In Vivo Plaque T2* Measurement and Ex Viv
Variable Symptomatic Patients
T2*, ms 20.0 1.8
EPR Fe(III), g/g 7.3 3.8
ICP-MS total iron, g/g 138.6 36.5
ICP-MS copper, g/g 3.2 0.5
ICP-MS calcium, mg/g 37.5 10.8
Inductively-coupled plasma mass spectroscopy (ICP-MS) results are expressed i
EPR  electron paramagnetic resonance.alcium and more copper by ICP-MS in symptom-
roducing versus non–symptom-producing plaques.
Overall, the majority of plaques demonstrated ad-
anced features (Stary class IV to VI). Histopathology
emonstrated both red blood cell degradation as well
s plaque disruption with intraplaque hemorrhage,
oth of which may be sources of intraplaque iron (Fig.
). A positive correlation was found between glyco-
horin A and Prussian blue (p  0.05), as well as
etween glycophorin A and Factor VIII (p  0.001).
I S C U S S I O N
n patients with carotid artery atherosclerosis, in vivo
RI measurement of intraplaque magnetic inhomo-
eneity with T2* identified variable intraplaque iron
ontent and speciation; this quantitative, reproducible
arameter distinguished symptomatic from asymptom-
tic patients. With ex vivo analyses, total iron was
imilar in both groups, but low molecular weight
e(III) was lower in symptom-producing plaques; con-
ersion to other forms of iron may produce this short-
ning of T2* relaxation time (Fig. 6). Both ferritin and
emosiderin are known to significantly shorten T2*
elaxation time (29); in fact, T2* may be considered a
biomarker” of iron aggregation (30). Both iron and
opper have been implicated in previous studies of
etal ions in atherosclerosis development, although
ron affects T2* to a much greater extent, because its
agnetic moment is larger and its quantity in plaque is
early 2 orders of magnitude greater than that of
opper (11,12,31). Since similar levels of total iron were
resent in both groups, our results are consistent with a
hift of iron from low molecular weight paramagnetic
e(III) complexes, and possibly from EPR-invisible
iamagnetic Fe(II) complexes, to other species such as
emosiderin and ferritin, which are known to markedly
horten the T2* relaxation time.
The majority of previous work in humans to ad-
ress the role of iron in atherosclerosis has lacked
irect examination of human atherosclerotic plaques
or iron, making it difficult to lend credence to the iron
on Quantiﬁcation
Asymptomatic Patients p Value
34.4 2.7 0.0006
17.7 4.0 0.025
165.8 48.3 NS
1.7 0.1 0.004
123.6 19.3 0.003
ms of dry weight of samples.o Ir
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55ypothesis or make a direct histological link to plaque
omposition itself. While systemic factors may con-
ribute to a milieu that favors atherosclerosis, plaque
evelopment occurs in discrete locations, mandating
irect studies of plaque’s microenvironment to gain
nsight into molecular mechanisms. We found that in
ymptomatic patients, a shift of the type of iron
omplexes present seemed to occur with shortening of
2*. This shift could be secondary to an increase in
erritin-bound iron, which is consistent with previous
tudies documenting increased levels of ferritin in
therosclerotic plaque and a positive correlation be-
ween ferritin levels and apoptotic cell death (32,33).
t is notable that iron in plaques on histopathology
ccurred both at sites of intraplaque hemorrhage, an
stablished marker of plaque instability (5), as well as
n macrophages. The correlation of clinical manifes-
ations with explanted iron quantification supports the
otion that iron does play a role in the natural history
f atherosclerosis.
Previous studies have implemented conventional
1W, T2W, proton density, and time-of-flight im-
ging with good ability to classify plaques, particularly
hose with intraplaque hemorrhage, based on multi-
ontrast analysis (22). The limited number of patients
ndergoing multicontrast MRI with T2* quantifica-
ion precludes direct comparison, especially in light of
ariable plaque classification schemes that are based on
ubjective assessment of multicontrast magnetic reso-
ance images, even among senior investigators
34,35). However, given: 1) its greater sensitivity to
nd specificity for intraplaque iron; 2) its clinical
elevance in distinguishing symptom-producing
laques; and 3) its quantitative nature that does not
equire qualitative assessment of relative signal in-
ensity, plaque T2* quantification as developed in
his work should be a useful addition to the assess-
Figure 5. Plaque Histopathology
(Left) Histopathological section with Prussian blue staining at low a
(Middle) Staining for glycophorin A shows evidence of red blood c
demonstrates neovascularization in the plaque neointima.ent of patients with carotid artery disease. Cur-ent decision-making regarding carotid endarterec-
omy relies on patient history and percent stenosis,
espite a stroke rate of 15% to 20% in asymptomatic
atients with 50% to 69% stenosis that do not
ndergo revascularization (36). The prognostic
alue of multispectral qualitative plaque MRI and
ntraplaque T2* measurement would be best evalu-
ted in a prospective study, as we have ongoing at
ur institution. This approach may help identify
symptomatic patients with “vulnerable plaque”
hat would benefit from interventions to reduce the
troke rate in this population.
Continued technical improvements in MRI may
urther enhance the utility of this study. T2*-weighted
maging using 3-T systems should theoretically ben-
fit from the greater sensitivity to T2* effects with
high (inset) magniﬁcations demonstrates iron deposits in plaque.
embrane fragments within plaque. (Right) Staining for Factor VIII
5Fe2O3 – 9H2O
(Ferrihydrite
Ferritin/Hemosid
Fe(III) Fe(II)
O2
Asymptomatic Symptomat
Figure 6. Model of Hypothesized Mechanism Underlying Observe
Although our work demonstrated similar total iron in symptom-pro
versus non–symptom-producing carotid plaques, the former group
paramagnetic iron by EPR and greater T2*-shortening iron species.
ference suggests a shift from paramagnetic Fe(III) to iron aggregate
have a greater effect on local magnetic susceptibility, measurable u
tissue-speciﬁc magnetic resonance imaging relaxation time T2*. Abbnd
ell m)
erin
ic
d Results
ducing
had less
This dif-
s that
sing the
revia-tions as in Figure 4.
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56ncreased field strength. Although susceptometry
echniques also have been used to measure tissue iron
37), we chose MRI for this work because it uniquely
rovides simultaneous high-resolution plaque imaging
o insure accurate localization of measurements. Fur-
hermore, the widespread availability of 1.5-T MRI
canners allows our novel T2*-based technique for
oninvasive plaque characterization to be readily im-
lemented clinically.
Because of the 2-dimensional nature of the T2*
cquisition, we could only select 1 slice for plaque T2*
easurement. Although the region of interest for T2*
easurement was drawn such that it encompassed the
ntirety of the plaque at a slice showing maximum
laque, this region might not necessarily reflect the
2* of the entire plaque. Such a volumetric assessment
ould be achieved with development of 3-dimensional
2* acquisition techniques. Nonetheless, our work did
emonstrate predictive value using single-slice in vivo
laque T2* compared with ex vivo EPR and ICP-MS
easurements of larger plaque sections supporting
urther work to measure T2* over an entire plaque
olume. Our results did indicate reproducibility of T2*
laque measurement in patients undergoing repeated
2* imaging at 1 setting as well as off-line quantifi-
ation of T2* images by multiple independent observ-
rs. Also, this work was not a slice-specific comparison
f MRI plaque morphology to histopathology.
ather, we implemented a novel noninvasive plaque
haracterization technique validated with ex vivo anal-
sis of the plaque. Further studies registering specific
maging slice locations with explanted sections may
elp determine the extent and significance of in-
raplaque T2* heterogeneity.
Much attention has focused on detecting athero-
clerosis with calcium screening. We found that
arotid plaques in symptomatic patients actually1981;1:1293–4. phages. J Lipid Resrevious work using B-mode ultrasound demon-
trating lower calcium content in carotid plaques
rom symptomatic versus asymptomatic patients
38). In addition, studies in which researchers have
sed histopathology and intravascular ultrasound of
he coronary arteries have demonstrated that lesions
ssociated with chronic stable angina are more
xtensively calcified than those associated with
cute coronary syndromes (39–41). In the current
tudy, there was concern that calcium would inter-
ere with the measurement of T2*, because calcium
roduces a very low signal intensity on T2*-
eighted gradient echo imaging, potentially short-
ning the T2* relaxation time. Ex vivo analysis
emonstrated lower calcium values in patients with
horter T2* times, indicating that the change could
ot be due to calcium but another substance,
amely iron.
O N C L U S I O N S
oninvasive carotid plaque T2* measurement dis-
inguished plaques that produce symptoms from
hose in asymptomatic patients undergoing carotid
ndarterectomy. Our results indicate the presence
f decreased levels of paramagnetic-Fe(III) com-
lexes and similar total iron levels. With T2*-
hortening, these results suggest a shift to aggregate
ron complexes that have greater local effects on
agnetic susceptibility. Further studies are war-
anted to identify changes in the amount, species,
nd chemistry of intraplaque iron during the course
f atherosclerosis development.
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